In a study of 1,452 parous and nulliparous women aged 18-35 years:
*A randomized controlled trial (N=82) tracked OC dosing for 3 months by electronic and wireless data collection. During the study period, half the participants (n=41) received a daily reminder text message.
IUD=intrauterine device; OCs=oral contraceptives
Access educational and support materials for you, your staff, and your patients.View All Materials
Browse frequently asked questions about Kyleena.See More Questions
Register to meet with a Bayer Sales Consultant to learn more about Kyleena and Bayer Pharmaceuticals.